Senator probes 340B programs at Cleveland Clinic, Bon Secours

Sen.BillCassidy(R-La.)StefaniReynolds/TheNewYorkTimesviaAPWASHINGTON—Thetop-rankingRepublicanontheSe DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr




hotspot

author：fashion    Page View：22139
Franklin faces
Adobe

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

advertisement

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In
Previous article： More doctors should go into startup world
Next article： Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections